Skip to main content
. 2022 Jan 28;23(3):1539. doi: 10.3390/ijms23031539

Figure 2.

Figure 2

Figure 2

Correlation analysis of CAP2, DLG1, and ADAM10 mRNA expression with age and PMI in the post-mortem dorsolateral prefrontal cortex and hippocampus of schizophrenia patients. Analysis of correlation between age and mRNA expression of CAP2, DLG1, and ADAM10 in the dorsolateral prefrontal cortex of (a,e,i) control subjects (CTRL, n = 19) and (b,f,j) schizophrenia patients (SCZ, n = 20). Correlation analysis between PMI and mRNA expression of CAP2, DLG1, and ADAM10 in the dorsolateral prefrontal cortex of (c,g,k) control subjects (n = 19) and (d,h,l) schizophrenia patients (n = 20). Analysis of correlation between age and mRNA expression of CAP2, DLG1, and ADAM10 in the hippocampus of (m,q,u) control subjects (CAP2/ADAM10: n = 20; DLG1: n = 19) and (n,r,v) schizophrenia patients (CAP2: n = 20; DLG1: n = 18; ADAM10: n = 19). Correlation analysis between PMI and mRNA expression of CAP2, DLG1, and ADAM10 in the hippocampus of (o,s,w) control subjects (CAP2/ADAM10: n = 20; DLG1: n = 19) and (p,t,x) schizophrenia patients (CAP2: n = 20; DLG1: n = 18; ADAM10: n = 19).